– Breadth of Alto’s pipeline and Precision Psychiatry Platform™ will be highlighted across twelve posters and presentations at the Society of Biological Psychiatry and American Society of Clinical ...
Alto Neuroscience presents at key healthcare conferences this month, focusing on its pipeline after a 2024 trial failure. Investors await updates on the ALTO-101 Phase 2 data timeline. March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results